- Home
- BLCO vs XP Comparison
BLCO vs XP Comparison
Compare BLCO & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- XP
- Stock Information
- Founded
- BLCO 1853
- XP 2001
- Country
- BLCO Canada
- XP Cayman Islands
- Employees
- BLCO N/A
- XP N/A
- Industry
- BLCO Ophthalmic Goods
- XP Investment Bankers/Brokers/Service
- Sector
- BLCO Health Care
- XP Finance
- Exchange
- BLCO Nasdaq
- XP Nasdaq
- Market Cap
- BLCO 6.3B
- XP 7.3B
- IPO Year
- BLCO 2022
- XP 2019
- Fundamental
- Price
- BLCO $15.77
- XP $14.65
- Analyst Decision
- BLCO Buy
- XP Buy
- Analyst Count
- BLCO 12
- XP 6
- Target Price
- BLCO $19.82
- XP $20.33
- AVG Volume (30 Days)
- BLCO 751.8K
- XP 5.7M
- Earning Date
- BLCO 02-19-2025
- XP 02-18-2025
- Dividend Yield
- BLCO N/A
- XP 4.44%
- EPS Growth
- BLCO N/A
- XP 14.90
- EPS
- BLCO N/A
- XP 1.33
- Revenue
- BLCO $4,791,000,000.00
- XP $2,627,582,667.00
- Revenue This Year
- BLCO $17.29
- XP $24.20
- Revenue Next Year
- BLCO $5.47
- XP $11.25
- P/E Ratio
- BLCO N/A
- XP $11.01
- Revenue Growth
- BLCO 15.56
- XP 14.10
- 52 Week Low
- BLCO $13.16
- XP $10.82
- 52 Week High
- BLCO $21.69
- XP $26.31
- Technical
- Relative Strength Index (RSI)
- BLCO 32.89
- XP 63.06
- Support Level
- BLCO $15.62
- XP $14.54
- Resistance Level
- BLCO $16.60
- XP $15.43
- Average True Range (ATR)
- BLCO 0.46
- XP 0.46
- MACD
- BLCO -0.05
- XP 0.07
- Stochastic Oscillator
- BLCO 7.01
- XP 66.01
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.